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What is the magnitude of the 
problem?
Despite the significant shift in practice from general to spinal anaes-
thesia for caesarean section, avoidable anaesthetic deaths in South 
Africa (SA) persist. In the triennium 2011 - 2013, 71% of 105 anaes -
thesia-related deaths involved spinal anaesthesia, the majority of 
which were deemed avoidable.[1] Given that more than half (55.1%) 
of these deaths occurred at district-level hospitals, these institutions 
should be targeted for support and education, with context-sensitive 
solutions based on up-to-date evidence-based guidelines.
This brief review summarises the most recent data regarding 
hypotension during spinal anaesthesia for caesarean section. The 
authors discuss new insights into the predictors of hypotension, 
venous and arterial components of haemodynamic changes, dosing 
controversies and up-to-date treatment modalities.
How do we predict spinal 
hypotension?
Hypotension after spinal anaesthesia for caesarean section is a common 
clinical finding and causes major morbidity, and indeed, mortality, 
depending on the context. Predicting which parturients will experience 
major spinal hypotension remains a target of ongoing research. In 2014, 
an in-depth review was published locally, and further recent articles 
from SA have shed light on the matter. Research has shown a specific 
pattern of heart rate variability to be a risk factor for spinal hypotension. 
Bishop et al.[2] performed Holter continuous electrocardiogram (ECG) 
recordings for ≥5 minutes preoperatively on 102 elective patients due 
to undergo caesarean section. They investigated the low-frequency/
high-frequency (LFHF) ratio, a measure of heart rate variability, and 
compared this with baseline heart rate and body mass index (BMI) 
as other predictors. A logistic regression analysis was performed, 
which showed that an LFHF threshold of 2.0 was predictive of spinal 
hypotension (defined as systolic blood pressure <90 mmHg), with an 
odds ratio of 1.478 (p=0.046). In comparison, BMI and baseline heart 
rate were less predictive.
A further observational trial by the same authors[3] found that 
preoperative heart rate, mean arterial pressure (MAP) and maternal 
age were also predictive of spinal hypotension. A scoring system based 
on these variables (pulse rate >90 bpm, age >25 years, MAP <90 mmHg 
– the PRAM score) showed good discrimination, and patients had a 
53% chance of developing spinal hypotension if all three factors were 
present. This simple scoring system, although not validated in larger 
studies, is probably a more useful practical tool in resource-constrained 
environments compared with LFHF measurements. In other studies, a 
BMI >25 kg/m2 has been shown to be a predictor of hypotension, but 
this was not supported by the PRAM study group.
Recent data showed the benefit of point-of-care echocardiography in 
the prediction of spinal hypotension. A prospective observational trial 
assessing changes in the sub-aortic velocity time integral (VTI) after 
a 45° passive leg raise, found that when the change in VTI was >21%, 
the area under the receiver operating characteristics (ROC) curve for 
predicting spinal hypotension was highly predictive at 0.8 (confidence 
interval 0.6 - 0.9; p=0.0001). Until point-of-care echocardiography and 
the associated skills become more widely available, this will remain a 
research tool.
What is the correct spinal anaesthesia 
dose?
What, then, is the safe and effective dose of intrathecal local 
anaesthetic? Although a smaller dose is attractive in terms of a lower 
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incidence of hypotension and nausea and vomiting, it is associated 
with increased breakthrough pain. A meta-analysis of 12 randomised 
control trials comparing low-dose bupivacaine (i.e. <8 mg/<1.8 mL) 
with a normal dose of ≥8 mg, showed a 3-fold increase in the need 
for analgesic supplementation intraoperatively; the number-needed-
to-treat for additional harmful outcomes was 4.[4] 
Historically, there has been a perception that a non-adjusted 
spinal dose in obese patients would cause a higher and unpredictable 
block owing to previous articles suggesting increased block height 
in such patients. This is concerning in our country, where nearly 
70% of women are overweight or obese. After a recent article 
suggesting that the effective dose 95% (ED95) for intrathecal local 
anaesthesia for obese and normal BMI parturients is similar, a 2016 
study performed by Ngaka et al.[5] specifically addressed this issue. 
These authors compared a group of patients at term with a BMI of 
<32 kg/m2 with another whose BMI was >40 kg/m2, each receiving 
identical doses of local anaesthetic. Although the temperature block 
was two dermatomes higher at 25 minutes in the morbidly obese 
group, and there was a 20-minute greater block regression time, 
there were no block levels higher than T1, and no differences in 
phenylephrine requirements or in reduction of peak flow rate after 
spinal anaesthesia. Other studies showed no correlation between 
height, weight, BMI and block height with standard (12 mg) doses 
of spinal bupivacaine. Subsequent reviews have thus concluded that 
dose adjustment of hyperbaric bupivacaine is unnecessary in obese 
patients. 
What is the effect of aortocaval 
compression on spinal hypotension?
Left lateral tilt (15°) of the parturient after spinal anaesthesia to 
ensure displacement of the gravid uterus and subsequent aortocaval 
compression has been standard practice since the 1970s. Lee et al.[6] 
recently called this practice into question, randomising 100 women 
to either the supine position or 15° left lateral tilt. Maternal blood 
pressure was maintained with titrated phenylephrine infusions or 
boluses in both groups. There was no difference in the primary 
outcome, i.e. neonatal acid base balance. However, the mean phenyl-
ephrine requirement was higher and mean cardiac output decreased 
in the supine group. An accompanying editorial urges caution in 
abandoning the classic approach, as some patients have an exagger-
ated response to aortocaval compression, including occasional reflex 
bradycardia and precipitous hypotension. 
How does the venous circulation affect 
spinal hypotension? 
Due to the physiological changes of pregnancy, healthy women at term 
have an increase in plasma volume of ~40%, which usually compensates 
for the sympathectomy associated with spinal anaesthesia. However, 
after haemorrhage, sympathectomy, as well as the usual arteriolar 
dilatation associated with spinal anaesthesia, results in venodilatation 
and rapid decompensation as blood shifts from the stressed volume to 
the unstressed volume in the splanchnic circulation. 
In a recent meta-analysis, Melchor et al.[7] demonstrated that 
the use of colloids, either as a preload or a co-load, is associated 
with significantly reduced rates of hypotension compared with 
crystalloids. However, no method of fluid administration effectively 
prevents hypotension. Therefore, additional means of maintaining 
maternal blood pressure are required. In the past 10 - 12 years, 
research focused on the arterial component of spinal hypotension, 
the effect of regional anaesthesia on the systemic vascular resistance 
(SVR) in both healthy women and those with pre-eclampsia, as well 
as the physiological effect of vasopressors on the SVR. In healthy 
women undergoing caesarean section under spinal anaesthesia, 
minimally invasive cardiac output measurements showed that when 
the MAP decreases by 20%, the SVR decreases by 35% and the heart 
rate, stroke volume and cardiac output increase by 12%, 9% and 
22%, respectively.[8] The same article showed that phenylephrine 
restores haemodynamics to baseline, compared with ephedrine, 
which further increases cardiac output and is associated with a delay 
to peak pressor effect (undesirable in terms of nausea and vomiting).
There is little information on the effects of spinal anaesthesia on the 
venous circulation in the fluid-replete parturient. Kuhn et al.[9] used 
leg wrapping after spinal anaesthesia to reduce hypotension instead 
of no intervention, and showed that venodilatation does contribute to 
spinal hypotension. This was, however, a far lesser effect than that of 
the arteriolar component, and of the effect of phenylephrine infusion 
in counteracting this decrease in SVR.
Why should phenylephrine be used in 
spinal hypotension?
It is now well accepted that the best approach to spinal hypotension 
is by means of a combination of intravenous crystalloid co-load 
and phenylephrine. This is the most effective method of ensuring 
maternal safety and comfort and preventing neonatal acidosis. In 
a randomised double-blind trial comparing varying set rates of 
phenylephrine infusion, 100 µg/min decreased maternal cardiac 
output and heart rate by up to 20%. An infusion at a rate of 
25 - 50 µg/min was therefore sufficient to maintain appropriate 
maternal haemodynamics without exposing the fetus to large doses 
of phenylephrine and is the current recommendation. Although 
ephedrine is a commonly used drug in the management of spinal 
hypotension, it has concerning effects on the fetus as a result of 
stimulation of fetal metabolism after placental transfer of ephedrine 
and the resulting stimulation of fetal beta-adrenergic receptors. In a 
study of 109 elective caesarean section patients at term comparing 
high-dose ephedrine with phenylephrine infusions, titrating the 
latter to systolic blood pressure resulted in better fetal blood gases 
(umbilical artery pH 7.25 v. 7.34, base deficit −4.8 v. −1.9 mmol/L, 
and lactate 4.2 v. 2.2 mmol/L, respectively). A recent meta-analysis 
reported a 5-fold increase in the risk of fetal acidosis and larger base 
deficit with ephedrine than with phenylephrine.[10] 
A recent randomised trial on the haemodynamics of vasopressors 
during spinal anaesthesia in cases of pre-eclampsia, demonstrated 
a significant difference in the effect of vasopressors on SVR, with 
phenylephrine rapidly restoring SVR to baseline, and ephedrine, even 
in large doses, being less effective. Phenylephrine also reduces cardiac 
output, but as an appropriate response to the increase in cardiac 
output resulting from the spinal anaesthesia (Fig. 1).[11] 
Another trial comparing two groups of women with severe pre-
eclampsia and fetal compromise, who were treated with ephedrine 
and phenylephrine boluses, revealed no significant differences in 
the primary outcome of umbilical artery base excess (mean −4.9 
(standard deviation (SD) 3.7) v. −6.0 (4.6) mmol/L for ephedrine 
and phenylephrine, respectively; p=0.29).[12] There were also no 
differences in 1-minute Apgar scores or lactate levels, suggesting 
that in women with severe pre-eclampsia and fetal compromise, the 
choice of vasopressor does not affect fetal acid base status. 
Anaesthetists should also bear in mind that cardiac output 
response to phenylephrine is preload dependent. Work done in a 
porcine general anaesthesia model demonstrated that cardiac output 
decreases in response to phenylephrine administration when the 
patient is fluid replete and increases if the animal is fluid depleted. 
Therefore, what is the best method of administering phenyl -
ephrine? Simple titrated phenylephrine infusions initiated immedi-
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ately after the induction of spinal anaesthesia are certainly less labour 
intensive, are safe and are associated with a low incidence of maternal 
nausea and vomiting. Closed-loop, feedback computer-controlled 
phenylephrine infusions provide even tighter blood pressure control. 
However, this method requires specialised equipment and is not 
practicable in limited-resource environments. Phenylephrine boluses 
(50 - 100 µg) may be equally effective in preventing and treating 
spinal hypotension. The importance lies in choosing the best method 
appropriate to the maternal condition, local context and physician 
skill and experience. All the potential administration methods and 
doses have been well summarised in a recent review.[13]
Should one consider noradrenaline?
There are now several articles advocating the use of noradrenaline 
rather than phenylephrine for the treatment of spinal hypotension 
because of its moderate beta-adrenergic effects on maternal heart 
rate. In a randomised study of 104 healthy patients undergoing 
caesarean delivery under spinal anaesthesia, at 5 minutes after local 
anaesthetic injection a noradrenaline infusion maintained maternal 
cardiac output and heart rate better than a phenylephrine infusion. 
Maternal blood pressures and neonatal Apgar scores were similar 
with regard to the relevant infusions. Further work determined 
that phenylephrine 100 µg equals noradrenaline 8 µg. A subsequent 
editorial called into question the need for change to a more potent 
drug, suggesting that the burden of proof for noradrenaline to replace 
phenylephrine has not as yet been met, in contrast to the proven 
benefit of phenylephrine over ephedrine.[14]
What is the approach to a patient who 
develops bradycardia under spinal 
anaesthesia?
It is imperative that immediately after a spinal local anaesthetic 
has been injected, close attention is paid to communication with 
the patient, heart rate changes and pulse volume. Hypotension and 
bradycardia should be treated with ephedrine and/or anticholinergic 
agents after increasing left lateral tilt, if necessary. 
Bradycardia is not an uncommon occurrence when a patient with 
spinal hypotension is treated with the enthusiastic administration of 
phenylephrine. The use of prophylactic glycopyrrolate in conjunction 
with a phenylephrine infusion was shown to improve cardiac 
output and heart rate, but at the cost of increased hypertension 
and an increased incidence of dry mouth. Baroreceptor-mediated 
bradycardia in response to an increased blood pressure after 
the administration of phenylephrine should not be treated with 
anticholinergics, as this may result in tachycardia and hypertension, 
particularly in pre-eclampsia. 
A recent meta-analysis demonstrated that prophylactic ondan-
setron reduced the incidence of spinal hypotension, vasopressor 
consumption and nausea and vomiting in the obstetric and non-
obstetric populations, but the clinical significance is uncertain. The 
exact mechanism is unclear; however, it is suggested that 5-hydroxy-
tryptamine (5-HT3)-receptor antagonism during the sympathectomy 
induced by spinal blockade may decrease the risk of mechanorecep-
tor activation in the left ventricle, which could have resulted in the 
subsequent activation of the Bezold-Jarisch reflex, with hypotension 
and bradycardia.
Are there any practice guidelines 
available?
Internationally, a consensus statement has recently been published, 
which emphasises the importance of pattern recognition of the 
haemodynamic changes associated with spinal anaesthesia, and 
describes in detail the management of spinal hypotension with 
vasopressors during caesarean section.[10] Recommendations for best 
practice include the use of alpha1-agonists for the treatment and 
prevention of hypotension (using boluses or infusions); left lateral 
uterine displacement and crystalloid co-loading or colloid preloading 
in addition to vasopressors for maintenance of the systolic blood 
pressure at ≤90% of baseline, and targeting maternal heart rate as a 
surrogate marker for cardiac output, i.e. tight haemodynamic control; 
and the use of phenylephrine infusions at 25 - 50 mg/min immediately 
after intrathecal injection. In patients with pre-eclampsia, fewer 
vasopressors are usually required, probably secondary to the 
vasoconstrictor state associated with this condition.[15]
Guidelines have recently been published on the diagnosis and 
manage ment of spinal anaesthesia with high sensorimotor block.[16] The 
main principles remain: (i) preparation for and anticipation of high 
spinal anaesthesia, including drawing up appropriate drugs; (ii) early 
recognition; (iii) respiratory support and prompt administration of 
ephedrine (due to the likelihood of cardiac deafferentation); (iv) avoid ance 
of cardiorespiratory depressants, such as propofol or thiopentone; 
(v) administration of adrenaline via a peripheral vein if necessary 
to maintain cardiac output; and (vi) ongoing monitoring of the 
patient for haemodynamic instability and recovery from respi-
ratory failure.
‘Context is king’[17] 
Much of the mechanistic research performed on the haemodynamic 
effects of spinal anaesthesia, and of vasopressors for spinal 
hypotension, has been carried out in high-resource environments. 
These findings have greatly improved knowledge and understanding. 
However, the application of the findings to a resource-limited 
situation remains challenging. The use of simple phenylephrine 
infusions has been successfully demonstrated to good effect in the SA 
context[18] and should encourage SA researchers who are appropriately 
applying up-to-date information. Ongoing data collection and 
context-sensitive research are to be encouraged, and audits such as 
the Confidential Enquiry into Maternal Deaths in SA and initiatives 
such as the SA Perioperative Research Outcomes Group (SAPORG) 
are specifically targeting the improvement of obstetric and perinatal 
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Fig. 1. Percentage change in haemodynamic variables over 150 seconds after 
administration of phenylephrine 50 (range 50 - 150) µg or ephedrine 15 
(range 7.5 - 37.5) mg for spinal hypotension. (Adapted from Dyer et al.,[11] 
with permission. HR = heart rate; CO = cardiac output; MAP = mean arterial 
pressure; SV = stroke volume; SVR = systemic vascular resistance; pre-vaso = 
mean value immediately prior to treatment of spinal hypotension.) 
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care. Given that the recent continent-wide African Surgical Outcomes 
Study (ASOS) reported caesarean section as the most commonly 
performed procedure,[19] and that the mortality associated with spinal 
anaesthesia remains significant, spinal hypotension should ideally be 
avoided. When it does occur, it is critical that the associated clinical 
deterioration is immediately identified and appropriate management 
rapidly initiated.
Key points
• Substandard treatment of spinal hypotension and associated 
complications are responsible for a large proportion of deaths in SA 
for caesarean section under spinal anaesthesia.
• Spinal anaesthesia is absolutely contraindicated if the parturient is 
hypovolaemic.
• Spinal hypotension may in some cases be predicted by simple 
parameters, such as age, preoperative heart rate and preoperative 
mean arterial pressure.
• Left lateral tilt is still advised, despite the absence of strong supporting 
evidence. 
• The dose of spinal bupivacaine should not be reduced in obese 
patients.
• Crystalloid co-loading is an adequate fluid strategy in most cases, 
but is of limited efficacy in the prevention of hypotension. 
• It is imperative that immediately after the patient is placed supine, 
close attention is paid to communication with her, heart rate changes 
and pulse volume.
• Early intervention with phenylephrine is the first-line approach for 
hypotension if the heart rate is preserved under spinal anaesthesia.
• Phenylephrine boluses (50 - 100 µg) or infusions (25 - 50 µg/min) are 
easy to administer and maintain baseline maternal haemodynamics, 
and are applicable to the SA context.
• Noradrenaline has been used successfully to prevent spinal 
hypotension, but evidence does not yet suggest a change of practice.
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